About Us: Developing expert computer systems and facilitating data-sharing in the life science industries
We accelerate the discovery pipeline of the life sciences industry by enabling scientifically robust decisions to be made faster through advanced analytics which are informed by our position as the industry’s honest broker.
Products and Initiatives
State-of-the-art computer software for the advancement and acceleration of discovery in chemistry and the life sciences. Lhasa software aids in regulatory submission and helps scientists to work more efficiently and effectively, expediting development.
Lhasa is also involved in a variety of collaborative initiatives. Find out more using the links below.
Lhasa Symposia
Lhasa Symposia offer an excellent opportunity for member representatives to join with Lhasa Limited scientists and staff, with the purpose of sharing knowledge and views on scientific issues and Lhasa Limited products.
Each Lhasa Symposium will focus on a different scientific area relevant to the industry at that time.
Your complete solution for the ICH M7 Guidelines
Lhasa Limited can help you to organise the relevant information for an ICH M7 submission. Using the ICH M7 functionality within the Nexus Suite, Derek and Sarah Nexus are brought together to provide the expert rule-based and statistical-based in silico predictions required under ICH M7.
Events
Lhasa Limited regularly attends relevant conferences around the world in order to meet with its members and prospects and to share knowledge and updates. Lhasa also holds its own face-to-face and virtual events.
Publications
Lhasa Limited frequently publishes articles, posters and presentations into its library to ensure its members and prospects are kept up-to-date with research and developments.
-
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines
September 2022
-
How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497
August 2022
-
Validation of Nexus v.2.5.2 for Ames Mutagenicity
August 2022
-
Letter to the editor of Heliyon re: determination of dimethylamine and nitrite in pharmaceuticals by ion chromatography to assess the likelihood of nitrosamine formation
July 2022
News
For recent News and Press Releases from Lhasa Limited, visit our News library.
-
Structurally complex and API-like nitrosamine data added to the Complex Nitrosamines Database
Aug 11 2022
-
AOP-Wiki announce latest release including Wiki Kaptis
Jul 28 2022
-
New data released to Vitic AI/PDE project to enhance the safety of drug substances
Jul 13 2022
-
2022.1.0 Vitic Intermediates data release
Jun 8 2022
-
Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessments
May 17 2022
-
Lhasa Limited announces the anticipated launch of a Federated Learning Hackathon
May 3 2022
About LHASA
We accelerate the discovery pipeline of the life sciences industry by enabling scientifically robust decisions to be made faster through advanced analytics which are informed by our position as the industry’s honest broker.
Our technology is uniquely designed by scientists, for scientists, and is developed in collaboration with industry stakeholders and regulators. Our not-for-profit status ensures that our sole focus is helping our members to be successful and thereby delivering public benefit.
Useful links
Staff Profiles
Find out more about our talented staff.
Current Vacancies
Want to work for Lhasa? Check out our careers page.
How to find us
Find out how to get to Lhasa's offices.
What are Lhasa Symposia?
Find out more about Lhasa's Symposia.
